BioDiscovery

BioDiscovery is a scientific software company based in El Segundo, California, focused on genetic research and genomic analysis.

Products

BioDiscovery's software product consists of three umbrella offerings:

• Nexus Copy Number (for microarray and NGS copy number analysis)
• Nexus Expression (for microarray and NGS gene expression)
• ImaGene (machine vision microarray analysis)

In addition, the company hosts Nexus DB (using Amazon's AWS as of October 2011), which is a cloud-based collaborative extension to the Nexus product line.

Scientific references

BioDiscovery's products have been used in research and publication, and have numerous peer-reviewed citations, including:

Cell: Identification of PHLPP1 as a Tumor Suppressor Reveals the Role of Feedback Activation in PTEN-Mutant Prostate Cancer Progression.^[1]

Nature: A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1.^[2]

European Journal of Human Genetics: Practical guidelines for interpreting copy number gains detected by high-resolution array in routine diagnostics.^[3]

Roche.^[4]

Application of Nexus Copy Number Software for CNV Detection and Analysis. Darvishi K. Curr Protoc Hum Genet. 2010 April; Chapter 4: Unit4.14.

History

BioDiscovery was founded in 1997 in Los Angeles, California, and has been focused on analyzing data from high-throughput microarrays and next-generation sequencing (NGS). The company's present headquarters are in El Segundo, California.

See also

• Microarray
• Genomics
• Cytogenetics

References